Bristol -Myers Squibb Company and Otsuka Pharmaceutical Co. Ltd
Bristol-Myers Squibb and Otsuka Receive Positive CHMP Opinion for ABILIFY(R) (aripiprazole) in Bipolar I Disorder
Paris and Uxbridge, England (ots/PRNewswire) - Bristol-Myers Squibb (NYSE: BMY) and Otsuka Pharmaceutical Europe Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion on the Marketing Authorisation Application ...